quinoxalines has been researched along with way 100135 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagdy, E; Harsing, LG | 1 |
| Aldegunde, M; Mancebo, MJ; Pérez-Maceira, JJ | 1 |
2 other study(ies) available for quinoxalines and way 100135
| Article | Year |
|---|---|
The role of various calcium and potassium channels in the regulation of somatodendritic serotonin release.
Topics: Animals; Axons; Calcium Channels; Dendrites; Hippocampus; Male; Piperazines; Potassium Channels; Quinoxalines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 1995 |
Serotonin-induced brain glycogenolysis in rainbow trout (Oncorhynchus mykiss).
Topics: Animals; Benzopyrans; Brain; Glycogen; Glycogen Phosphorylase, Brain Form; Glycogenolysis; Indoles; Injections, Intraperitoneal; Injections, Intraventricular; Morpholines; Oncorhynchus mykiss; Piperazines; Pyrazines; Pyridines; Quinoxalines; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Thiophenes; Time Factors | 2012 |